The role of stereotactic magnetic resonance-guided adaptive radiation therapy (SMART) in locally advanced and borderline resectable pancreatic cancer
Annals of Translational Medicine · 2024-12 · 12 (6) · 122-122
DOI: 10.21037/atm-24-170 ↗Kurz gefasst
Editorial in der Zeitschrift Annals of Translational Medicine, 2024-12. Verfasst von Zhu Chuen Oong und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
ORCID-Profile: Zhu Chuen Oong, Ganesh Radhakrishna
Zitieren
APA
Oong, Z. C., & Radhakrishna, G. (2024). The role of stereotactic magnetic resonance-guided adaptive radiation therapy (SMART) in locally advanced and borderline resectable pancreatic cancer. Annals of Translational Medicine, 12(6), 122-122. https://doi.org/10.21037/atm-24-170
Vancouver
Oong ZC, Radhakrishna G. The role of stereotactic magnetic resonance-guided adaptive radiation therapy (SMART) in locally advanced and borderline resectable pancreatic cancer. Annals of Translational Medicine. 2024;12(6):122-122. doi:10.21037/atm-24-170
BibTeX
@article{Oong2024,
author = {Oong, Zhu Chuen and Radhakrishna, Ganesh},
title = {The role of stereotactic magnetic resonance-guided adaptive radiation therapy (SMART) in locally advanced and borderline resectable pancreatic cancer},
journal = {Annals of Translational Medicine},
year = {2024},
volume = {12},
number = {6},
pages = {122--122},
doi = {10.21037/atm-24-170}
}
EUVIMED